Cardiac tamponade in Hodgkin lymphomaRETTER, Andrew; ARDESHNA, Kirit M; ODRISCOLL, Aisling et al.British journal of haematology. 2007, Vol 138, Num 1, issn 0007-1048, 2Article

Neurolymphomatosis in a patient with lymphoblastic lymphomaWAN, Ming Young S; ARDESHNA, Kirit M; BOMANJI, Jamshed et al.British journal of haematology. 2012, Vol 156, Num 6, issn 0007-1048, p. 691Conference Paper

Guideline on the prevention of secondary central nervous system lymphoma: British Committee for Standards in HaematologyMCMILLAN, Andrew; ARDESHNA, Kirit M; CWYNARSKI, Kate et al.British journal of haematology. 2013, Vol 163, Num 2, pp 168-181, issn 0007-1048, 14 p.Article

Treatment for lymph node tuberculosisSELLAR, Rob S; CORBETT, E. L; D'SA, Shirley et al.BMJ. British medical journal (International ed.). 2010, Vol 340, Num 7747, pp 653-655, issn 0959-8146, 3 p.Article

The upregulation of CC chemokine receptor 7 and the increased migration of maturing dendritic cells to macrophage inflammatory protein 3β and secondary lymphoid chemokine is mediated by the p38 stress-activated protein kinase pathwayARDESHNA, Kirit M; PIZZEY, Arnold R; WALKER, Simon J et al.British journal of haematology. 2002, Vol 119, Num 3, pp 826-829, issn 0007-1048, 4 p.Article

Autologous stem cell transplantation remains beneficial for patients relapsing after R-CHOP chemotherapy and who respond to salvage chemotherapyMOORE, Sally; PEGGS, Karl; THOMSON, Kirsty et al.British journal of haematology. 2012, Vol 156, Num 1, pp 142-144, issn 0007-1048, 3 p.Article

Rituximab in combination with CODOX-M/IVAC: a retrospective analysis of 23 cases of non-HIV related B-cell non-Hodgkin lymphoma with proliferation index >95%MOHAMEDBHAI, Sajir G; SIBSON, Keith; MARAFIOTI, Teresa et al.British journal of haematology. 2011, Vol 152, Num 2, pp 175-181, issn 0007-1048, 7 p.Article

Conventional second-line salvage chemotherapy regimens are not warranted in patients with malignant lymphomas who have progressive disease after first-line salvage therapy regimensARDESHNA, Kirit M; KAKOUROS, Nicholaos; WENDI QIAN et al.British journal of haematology. 2005, Vol 130, Num 3, pp 363-372, issn 0007-1048, 10 p.Article

Autologous stem cell transplantation for follicular lymphoma is of most benefit early in the disease course and can result in durable remissions, irrespective of prior rituximab exposureKOTHARI, Jaimal; PEGGS, Karl S; BIRD, Antonia et al.British journal of haematology. 2014, Vol 165, Num 3, pp 334-340, issn 0007-1048, 7 p.Article

Guidelines for the first line management of classical Hodgkin lymphomaFOLLOWS, George A; ARDESHNA, Kirit M; BARRINGTON, Sally F et al.British journal of haematology. 2014, Vol 166, Num 1, pp 34-49, issn 0007-1048, 16 p.Article

Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cyclesCUNNINGHAM, David; HAWKES, Eliza A; DAVIES, John et al.Lancet (British edition). 2013, Vol 381, Num 9880, pp 1817-1826, issn 0140-6736, 10 p.Article

Etoposide, methylprednisolone, cytarabine and cisplatin successfully cytoreduces resistant myeloma patients and mobilizes them for transplant without adverse effectsD'SA, Shirley; YONG, Kwee; WILLIAMS, Catherine D et al.British journal of haematology. 2004, Vol 125, Num 6, pp 756-765, issn 0007-1048, 10 p.Article